3 ms·
Given how the EU treated AstraZeneca, it makes sense that other companies would price in the expected risk of doing business with the EU.
by tomohawk 5y ago
Given how the EU treated AstraZeneca, it makes sense that other companies would price in the expected risk of doing business with the EU.